Back
Merus NV 10K Form
Sell
38
MRUS
Merus NV
Last Price:
$48.25
Seasonality Move:
4.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MRUS News And Ratings
See the #1 stock for the next 7 days that we like better than MRUS
MRUS Financial Statistics
Sales & Book Value
| Annual Sales: | $36.1M |
|---|---|
| Cash Flow: | $-66.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.41 |
| Price / Book: | 5.15 |
Profitability
| EPS (TTM): | -3.27000 |
|---|---|
| Net Income (TTM): | $-215.3M |
| Gross Margin: | $-24.6M |
| Return on Equity: | -38.4% |
| Return on Assets: | -31% |
Merus NV Earnings Forecast
Key Merus NV Financial Ratios
-
The Gross Profit Margin over the past 5 years for MRUS is -98.96%.
-
The Selling, General & Administrative Expenses for MRUS have been equal to 229.24% of Gross Profit Margin.
-
The Research & Development expenses have been 623.72% of Revenue.
-
The Net Earning history of MRUS is -595.93% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 2 years.
Merus NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRUS |
| CUSIP: | N5749R |
| Website: | merus.nl |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.54 |
| Quick Ratio: | 6.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |